Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/34333
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12502]
Metadata
Show full item record
PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE (PAF-AH) ACTIVITY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
Affilliation
Universidade do Estado do Rio de Janeiro. Hospital Pedro Ernesto. Serviço de Diabetes. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacoloiga. Rio de Janeiro, RJ. Brasil.
Universidade do Estado do Rio de Janeiro. Hospital Pedro Ernesto. Serviço de Diabetes. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacoloiga. Rio de Janeiro, RJ. Brasil.
Universidade do Estado do Rio de Janeiro. Hospital Pedro Ernesto. Serviço de Diabetes. Rio de Janeiro, RJ, Brasil.
Abstract in Portuguese
To evaluate platelet-activating factor acetylhydrolase (PAF-AH) activity and its relationship with clinical and demographic variables, metabolic control, apolipoprotein A and B levels and the susceptibility of low-density lipoprotein
(LDL) to in vitro oxidation in patients with type 1 diabetes mellitus (DM 1).
Abstract
To evaluate platelet-activating factor acetylhydrolase (PAF-AH) activity and its relationship with clinical and demographic variables, metabolic control, apolipoprotein A and B levels and the susceptibility of low-density lipoprotein (LDL) to in vitro oxidation in patients with type 1 diabetes mellitus (DM 1).
Share